Skip to content

DENTSPLY SIRONA XRAY Non-Controlling Interests

Non-Controlling Interests at other companies

Henry Schein logo
Henry ScheinHSIC
$653M+1.4%
Minerals Technologies logo
Minerals TechnologiesMTX
$33.4M-8.7%
Amentum Holdings logo
Amentum HoldingsAMTM
$94M-38.2%
Fortive logo
FortiveFTV
$8.3M+20.3%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$8.2M-5.7%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$12M-40.0%

Other financials

Income statement

See full
Revenue$880.0M+0.1%
Gross profit$427.0M-8.4%
Operating income-$35.0M-156%
Net income-$10.0M-150%
EPS (diluted)-$0.05-150%

Balance sheet

See full
Cash & equivalents$190.0M-52.3%
Total debt$2.3B-3.8%
Total equity$1.3B-34.4%
Total assets$5.2B-13.6%

Cash flow

See full
Operating cash flow$40.0M+471%
CapEx$52.0M+174%
Free cash flow-$12.0M0.0%

Valuation

See full
Market cap$2.11B-22.1%

Profitability

See full
Gross margin48.9%-2.6pp
Operating margin-14.1%-3.9pp
Net margin-17.1%-3.9pp
FCF margin2.8%-4.6pp

Returns & leverage

See full
Return on equity-37.7%+4.0pp
Debt / equity1.8×+0.6×
Current ratio1.5×+0.4×

Where this comes from

Reported directly by DENTSPLY SIRONA in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: DENTSPLY SIRONA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about DENTSPLY SIRONA's non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DENTSPLY SIRONA's non-controlling interests?
DENTSPLY SIRONA (XRAY) reported non-controlling interests of $1M in Q1 2026.
What is the long-term trend for DENTSPLY SIRONA's non-controlling interests?
Over 5 years (2020 to 2025), DENTSPLY SIRONA's non-controlling interests has grown at a -19.7% compound annual growth rate (CAGR), from $3M to $1M.
What does non-controlling interests mean?
Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.